Global Cannabis Infused Edible Products Market to Grow at a CAGR of 13.27% during 2025-2033

The global cannabis infused edible products market size is anticipated to reach USD 22.2 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 72.1 Billion by 2033, exhibiting a CAGR of 13.27% from 2025-2033. Growth can be attributed to legalization of cannabis for recreational and medical use, growing popularity of tobacco-free consumption forms, increasing awareness around the medical benefits of cannabis use, and increasing development of consumption formats.

Progressive Legalization and Regulatory Reforms Expanding Market Access

Cannabis edibles' increasing global market is a byproduct of the international decriminalization of the drug for recreational and medicinal use, alongside a recent cultural shift from official prohibition to social acceptance and decriminalization of the drug occurring globally. Countries where cannabis edibles can be legally manufactured and sold to human consumers under limited circumstances include the United States, Canada, Argentina, the Netherlands, Spain, Italy, Mexico, and Uruguay.

In the United States, state level legalization of cannabis has resulted in a patchwork style of regulation in what is one of the largest markets for cannabis in the world. In California, Colorado, Washington and Michigan the market is large and mature and regulated at the level of cultivation, manufacture, distribution, sale, and taxation. The legalization of cannabis in Canada for recreational use in 2018 has seen Canada considered a model for cannabis legalization with the establishment of a regulated cannabis market and investment into cannabis by the food and beverage industry.

Shifting Consumer Preferences Toward Healthier Consumption Methods

As a result of cannabis policy developments in some EU member states, pilot trials of cannabis in Germany, Italy, and Switzerland, and the legal regulation of medical cannabis in Italy and Switzerland, cannabis markets, including cannabis edibles, are likely to develop at the EU level. These may be driven by the potential economic and public health advantages of legal cannabis markets compared to prohibition and the demand for access from the legal supply chain.

The legalization trend continued in emerging markets in Latin America and the Asia Pacific, and is beginning in Africa as medical cannabis programs are starting and serious discussions are taking place on recreational legalization, allowing the cannabis industry to last as producers can scale production, distribution and product development.

Growing Recognition of Therapeutic Benefits and Medical Applications

Studies on edibles have increased due to the discovery of the therapeutic properties of cannabinoids CBD and THC. Research has looked at the use of cannabis for treating chronic pain, inflammation, anxiety, depression, insomnia, and nausea as well as neurological disorders. This scientific evidence has increased the willingness of patients to use cannabis as a medication instead of other medications that have side effects or potential for addiction.

Cannabis edibles may produce longer-lasting effects than when cannabis is smoked or vaporized, and are therefore used in the treatment of conditions that are best treated with longer action, such as chronic pain. Cannabis edibles have been used by patients with cancer to relieve nausea and vomiting from chemotherapy, increase appetite, and alleviate pain. Cannabis edibles may have particular application for pain, since they last much longer than inhalation. Effects can last many hours, so cannabis need not be consumed as frequently. Cannabis edibles also come in standardized doses which may allow patients to find their effective dose and titrate to their desired degree of cannabinoid exposure.

Get your Sample of Cannabis Infused Edible Products Market Insights for Free: https://www.imarcgroup.com/cannabis-infused-edible-products-market/requestsample

Industry Segmentation:

Segmentation by Product Type:

• Food
• Chocolates
• Gummies
• Mints
• Brownies
• Others
• Beverages
• Energy Drinks
• Fruit Juices
• Herbal Tea
• Others

Segmentation by Distribution Channel:

• Supermarkets and Hypermarkets
• Convenience Stores
• Specialist Stores
• Online Stores
• Others

Regional Insights:

• North America
• United States
• Canada
• Asia Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa

Who are the key players operating in the industry?

The report covers the major market players including:

• Baked Bros
• Bhang Corp.
• Botanic Lab
• Cannabinoid Creations
• Canopy Growth Corporation
• Charlotte's Web
• Dixie Brands Inc.
• Grön Confections
• Kats Botanicals
• Kaya Holdings Inc.
• Kiva Confections
• Koios Beverage Corp.
• Lord Jones (Zeus Cannabinoids, LLC)
• Medix CBD (CBD Capital Group)

Ask Our Expert & Browse Full Report with TOC & List of Figures: https://www.imarcgroup.com/request?type=report&id=2784&flag=E

About Us:

IMARC Group is a global management consulting firm that helps the world's most ambitious changemakers to create a lasting impact. The company provides a comprehensive suite of market entry and expansion services.

IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact US:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

United States: +1-201-971-6302